Atrial fibrillation is a major health, social, and economic problem affecting more than 2.5 million American adults. It’s becoming increasingly common as the population ages, with nearly 13.7% of people older than 80 affected. AF may be described by the ventricular response or by duration. A common complication of AF is stroke. Depending on the circumstances, AF can be treated with medications, such as anticoagulants and antiarrhythmics; cardioversion; and radiofrequency ablation with pacemaker. Patients undergoing cardioversion must be adequately anticoagulated when possible to prevent thromboembolism. Healthcare providers as a team should be able to recognize this common dysrhythmia, understand the etiologies and pathogenesis, and collaborate to educate patients about treatment options so they may make sound, evidence-based decisions about their treatment.
The goal of this program is to provide nurses, respiratory therapists, paramedics and EMTs, pharmacists, physical therapists and physicians with information about the incidence, etiology, pathophysiology, diagnosis and management of atrial fibrillation (AF). After studying the information presented here, you will be able to:
- Describe the mechanical events associated with AF with respect to cardiac anatomy and typical features of this dysrhythmia
- Identify the diagnostic approach to defining etiological factors for AF
- Discuss treatment strategies for AF
This course is intended for multiple professions, including nurses, pharmacists, physical therapists, and respiratory therapists.
Respiratory therapists: Take this version of the course to ensure you receive appropriate credit.
This program has been approved for 1 contact hour of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd., Suite 100, Irving, TX 75063. AARC Sponsor ID: 9514012. This is a non-traditional course. This course is approved from 1/17/2012 to 1/17/2014 and 2/17/2014 to 2/17/2016.
If you are a respiratory therapist, remember to give us your AARC member number when filling out your license number information.
OnCourse Learning is also approved by the Florida Board of Respiratory Care (provider #FBN 50-1489).
Course Originally Released on:
Date of Most Recent Review:
Course Termination/Update Date:
Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. OnCourse Learning guarantees this educational activity is free from bias. There is no commercial or in-kind support provided for this online educational activity.
Please see CE Course Instructions to learn how to earn CE credit for this module. For successful completion of this course, learners must read the course, and complete a posttest and evaluation survey.
This CE activity does not include any unannounced information about off-label use of a product for a purpose other than that for which is approved by the Food and Drug Administration (FDA).
The approval status for this educational activity, granted by the AARC, does not expressly or implicitly confer AARC endorsement of the activity’s content.
This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.